A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19

Karel F.A. Van Damme*, Levi Hoste, Jozefien Declercq, Elisabeth De Leeuw, Bastiaan Maes, Liesbet Martens, Roos Colman, Robin Browaeys, Cédric Bosteels, Stijn Verwaerde, Nicky Vermeulen, Sahine Lameire, Nincy Debeuf, Julie Deckers, Patrick Stordeur, Pieter Depuydt, Eva Van Braeckel, Linos Vandekerckhove, Martin Guilliams, Sjoerd T.T. SchettersFilomeen Haerynck, Simon J. Tavernier, Bart N. Lambrecht*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)
25 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology